These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 10774294
1. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands]. Voogd AC, Crommelin MA, Repelaer van Driel OJ, Nolthenius-Puylaert MC, van der Heijden LH, Coebergh JW. Ned Tijdschr Geneeskd; 2000 Apr 01; 144(14):659-63. PubMed ID: 10774294 [Abstract] [Full Text] [Related]
2. Results of 23,810 cases of ductal carcinoma-in-situ. Sumner WE, Koniaris LG, Snell SE, Spector S, Powell J, Avisar E, Moffat F, Livingstone AS, Franceschi D. Ann Surg Oncol; 2007 May 01; 14(5):1638-43. PubMed ID: 17245612 [Abstract] [Full Text] [Related]
3. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999. Wu X, Chen VW, Ruiz B, Andrews PA, Hsieh MC, Schmidt BA, Correa CN, Fontham ET. J La State Med Soc; 2003 May 01; 155(4):206-13. PubMed ID: 14506828 [Abstract] [Full Text] [Related]
4. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV. Breast Cancer Res Treat; 2009 May 01; 115(1):181-3. PubMed ID: 18516674 [Abstract] [Full Text] [Related]
5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI, Malone KE, Saltzman BS, Daling JR. Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564 [Abstract] [Full Text] [Related]
6. [Increased incidence of breast cancer in southeast Netherlands between 1960 and 1989]. Nab HW, van Beek MW, Crommelin MA, van der Heijden LH, Kluck HM, Coebergh JW. Ned Tijdschr Geneeskd; 1992 Sep 05; 136(36):1765-70. PubMed ID: 1328899 [Abstract] [Full Text] [Related]
7. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. Schouten van der Velden AP, Van Dijck JA, Wobbes T. Eur J Surg Oncol; 2007 May 05; 33(4):424-9. PubMed ID: 17084060 [Abstract] [Full Text] [Related]
8. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH, Farley DR. Surg Oncol; 2003 Dec 05; 12(4):221-40. PubMed ID: 14998563 [Abstract] [Full Text] [Related]
9. [The treatment of ductal carcinoma in situ (DCIS) of the breast]. Westenberg AH, Rutgers EJ, Peterse JL, Hendriks JH, Beex LV, van Tienhoven G. Ned Tijdschr Geneeskd; 2003 Nov 01; 147(44):2157-61. PubMed ID: 14626831 [Abstract] [Full Text] [Related]
10. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ. Ann Surg Oncol; 2008 Jan 01; 15(1):235-43. PubMed ID: 17987342 [Abstract] [Full Text] [Related]
11. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. EORTC Breast Cancer Cooperative GroupDepartment of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands. n.bijker@nki.nl, EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ. J Clin Oncol; 2006 Jul 20; 24(21):3381-7. PubMed ID: 16801628 [Abstract] [Full Text] [Related]
12. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Ann Surg Oncol; 2006 Jul 20; 13(7):967-76. PubMed ID: 16788759 [Abstract] [Full Text] [Related]
13. [Surgical aspects of breast cancer screening at our hospital]. Márkus B, Bajner A, Csejtei A, Firisz B, Hegedus A, Kocsis E, Kovács B, Pintér G, Tóth C. Magy Seb; 2006 Oct 20; 59(5):375-82. PubMed ID: 17201346 [Abstract] [Full Text] [Related]
14. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. Schouten van der Velden AP, van Vugt R, Van Dijck JA, Leer JW, Wobbes T. Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):703-10. PubMed ID: 17544591 [Abstract] [Full Text] [Related]
15. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G. Breast J; 2008 Nov 01; 14(2):135-40. PubMed ID: 18315691 [Abstract] [Full Text] [Related]
17. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening]. Ned Tijdschr Geneeskd; 2000 Jun 03; 144(23):1124-9. PubMed ID: 10876708 [Abstract] [Full Text] [Related]
19. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV. Breast; 2014 Feb 03; 23(1):63-8. PubMed ID: 24291376 [Abstract] [Full Text] [Related]
20. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]. André G, Tunon-de-Lara C, Macgrogan G, Laharie-Mineur H, Bussieres JE, Valentin F, Barreau B, Dilhuydy MH, Dilhuydy JM, Mauriac L, Debled M, Durand M, Mathoulin S, Avril A. J Gynecol Obstet Biol Reprod (Paris); 2007 May 03; 36(3):260-6. PubMed ID: 17376610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]